Literature DB >> 14977295

HIV/HCV coinfection: management update.

Daniel Alvarez1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14977295      PMCID： PMC2640582     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  9 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Antibodies to hepatitis C virus in low-risk blood donors: implications for counseling positive donors.

Authors:  H H Hsu; M Gonzalez; S K Foung; S M Feinstone; H B Greenberg
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

Review 3.  Diagnostic tests for hepatitis C.

Authors:  D R Gretch
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.

Authors:  Mayte Pérez-Olmeda; Marina Núñez; Miriam Romero; Juan González; Angeles Castro; José Ramón Arribas; José Pedreira; Pablo Barreiro; Javier García-Samaniego; Luz Martín-Carbonero; Inmaculada Jiménez-Nácher; Vincent Soriano
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

5.  Racial differences in the relationship between hepatitis C infection and iron stores.

Authors:  George N Ioannou; Jason A Dominitz; Noel S Weiss; Patrick J Heagerty; Kris V Kowdley
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Hepatitis C infection in African Americans: its natural history and histological progression.

Authors:  Thelma E Wiley; Jennifer Brown; Juliana Chan
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

7.  Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

Authors:  Ellen M Tedaldi; Rose K Baker; Anne C Moorman; Carlos F Alzola; Jack Furhrer; Robert E McCabe; Kathleen C Wood; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2003-01-14       Impact factor: 9.079

8.  The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy.

Authors:  Marina B Klein; Richard G Lalonde; Samy Suissa
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

9.  Hepatitis C and progression of HIV disease.

Authors:  Mark S Sulkowski; Richard D Moore; Shruti H Mehta; Richard E Chaisson; David L Thomas
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.